When will Lurasidone generics be available?
Generic versions of Lurasidone are expected to become available in 2024. The patent for Lurasidone has expired, opening the door for generic manufacturers to enter the market [1].
Who is making Lurasidone generics?
Several pharmaceutical companies are poised to launch generic Lurasidone. Sun Pharmaceutical Industries has announced its launch of generic Lurasidone tablets [1]. Teva Pharmaceuticals also received tentative approval for its generic version [2].
What is the difference between brand-name and generic Lurasidone?
Generic Lurasidone contains the same active ingredient, Lurasidone hydrochloride, as the brand-name drug, Latuda. These generics are bioequivalent, meaning they are expected to have the same safety and effectiveness profile. The primary difference lies in the inactive ingredients and, typically, the cost [1].
What is Lurasidone used for?
Lurasidone is an atypical antipsychotic medication used to treat schizophrenia in adults and adolescents, as well as bipolar depression in adults [1].
What are the potential risks of Lurasidone generics?
While generic drugs are designed to be therapeutically equivalent to their brand-name counterparts, patients should be aware of the possibility of minor variations in inactive ingredients that could cause individual sensitivities. As with any medication, patients should consult their healthcare provider about potential side effects and drug interactions [1].
Where can I find information on drug patents and exclusivity?
Information regarding drug patents and exclusivity periods, including for Lurasidone, can be found on resources like DrugPatentWatch.com [1].